79339266 - EXELIOM BIOSCIENCES

Information

  • Trademark
  • 79339266
  • Serial Number
    79339266
  • Registration Number
    7082665
  • Filing Date
    October 18, 2021
    3 years ago
  • Registration Date
    June 20, 2023
    a year ago
  • Transaction Date
    September 25, 2023
    a year ago
  • Status Date
    June 20, 2023
    a year ago
  • Published for Opposition Date
    April 04, 2023
    a year ago
  • Location Date
    June 20, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BUTLER, MIDGE FAE
  • Attorney Docket Number
    118171.0001
    Attorney Name
    Andrew Roppel
    Law Office Assigned Location Code
    L70
  • Owners
Mark Drawing Code
3000
Mark Identification
EXELIOM BIOSCIENCES
Case File Statements
  • GS0051: Pharmaceutical products for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; natural medicines for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; isotopes for medical use; yeast for medical, veterinary or pharmaceutical use; microbicides, namely, germicides for the prevention and treatment of immune-mediated diseases and infectious diseases; chemical preparations for medical use, namely, chemical preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; biochemical preparations for medical purposes, namely, biochemical preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; bacteriological preparations for medical use, namely, bacteriological preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; biological preparations for medical use, namely, biological preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; mixed biological preparations for medical use, namely, mixed biological preparations for the prevention and treatment of the immune-mediated diseases and infectious diseases; preparations of trace elements for human and animal consumption, namely, nutritional supplements, vitamins and dietetic beverages for the prevention and treatment of immune-mediated diseases and infectious diseases; preparations for enemas; nucleic acid sequences for medical and veterinary use; vaccines; vaccines for human use; blood substitutes for human use; beverages for babies, namely, infant formula, powdered milk for babies, baby food in beverage form, and nutritionally fortified beverages for medical purposes; mother's milk substitutes; drug delivery release agents in the nature of tablet coatings which facilitate the release of nutritional supplements; dietetic foods for clinical nutrition for medical purposes; dietetic foods adapted for medical purposes for sick people; dietetic foods for medical use; dietetic food adapted for diabetics; antioxidants; dietetic beverages for medical use; food supplements; protein supplement shakes; fruit juice beverages for diabetics, adapted for medical purposes; enzyme food supplements; protein food supplements; food supplements for controlling cholesterol; food supplements for infants; food supplements suitable for human consumption; food supplement with cosmetic effect; dietary supplements for persons with special diets; probiotic supplements; prebiotic supplements; dietetic confectionery products for medical use, namely, medicated candies for the prevention and treatment of intestinal omeothesis; dietary fibers, namely, dietary fiber for the prevention and treatment of intestinal omeothesis; beverage mixtures used as food supplements; slimming pills; freeze-dried food for medical use; medicinal drinks; vitamin and mineral products, namely, vitamin and mineral preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; dietetic foods adapted for medical use; dietetic preparations adapted for medical purposes; nutraceutical preparations for therapeutic or medical use, namely, nutraceuticals for the prevention and treatment of intestinal omeothesis; medicinal preparations used as additives for food intended for human consumption, namely, medicinal preparations for the prevention and treatment of intestinal omeothesis; multivitamin preparations; dietetic preparations for medical use; dietetic infusions for medical use; medicated food supplements; amino acids for pharmaceutical use; rubbing compounds for pharmaceutical use; milk ferments for pharmaceutical use; ferments for medical or veterinary use; ferments for pharmaceutical use; probiotic bacterial substances for medical use; medicinal herbs; medicines for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; plant-based medicines for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; medicated lozenges; lozenges for pharmaceutical use; anti-neoplastic preparations of microbial origin, namely, pharmaceutical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; plant preparations for medical use, namely, plant preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; bacteriological preparations for pharmaceutical use; biotechnological preparations for medical use; chemical-pharmaceutical preparations; chemical preparations for pharmaceutical use; pharmaceutical preparations for human use; probiotic preparations for medical use to help maintain a natural balance of the intestinal flora in the digestive system; chemical products for pharmaceutical use, namely, chemical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; injectable pharmaceutical products, namely, injectable pharmaceutical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; purgatives; medicinal preparations and substances, namely, drug delivery agents for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; mineral preparations and antibacterial substances for medical use; pharmaceutical preparations and substances, namely, pharmaceutical products for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; preparations of microorganisms for medical and veterinary use; biological reagents for medical use; chemical reagents for medical use; diagnostic reagents for medical use; chemical analysis reagents for medical use; reagents for microbiological analysis for medical use; regents for medical diagnosis; reagents for diagnostic tests for medical use; nutritive substances for microorganism cultures
  • GS0351: Compilation of scientific information into computer databases
  • GS0441: Health care services for human beings; pharmaceutical advice, namely, providing medical information services; advice in the field of dietetics and nutrition; health counseling services; information regarding health; provision of information relating to dietary and nutritional supplements; provision of information relating to dietary and nutritional recommendation services; providing information regarding food supplements and nutrition; preparing medical reports relating to health care, namely, providing medical information to patients; information and advisory services with respect to health; Advisory services relating to medical heath care; medical advisory services in dietetics; genetic testing on animals for diagnostic or treatment purposes; advisory and information services provided via the Internet with respect to development and research of pharmaceutical products; advisory and information services with respect to development and research of pharmaceutical products; advisory and information services with respect to development and research of biopharmaceutical products; information service relating to medicines; advisory services regarding the research and development of pharmaceutical products; information services concerning the research and development of pharmaceutical products; providing information relating to the preparation and dispensing of medicines; consultation with respect to pharmacy; pharmaceutical advice; advisory services with respect to nutrition; dietetic services; medical treatment of allergies
  • D10000: "BIOSCIENCES"
  • GS0421: Scientific and technological research services in the field of medicine; medical and pharmacological research services; laboratory analysis in the field of bacteriology; scientific research and analysis in the field of medicine; design and development of medical technologies; technical advice with respect to technical research in the field of food and beverages; technical advice with respect to research services concerning food and food supplements; development of new products; research laboratory services in the field of pharmaceuticals; providing scientific research services; providing information and results relating to scientific research from an online searchable database; preparation of reports concerning scientific research; preparation of scientific reports; research for new products for others; product research for others; chemical technology research; research and development in the field of biotechnology; research and development of new products; research and development of new products for third parties; scientific and industrial research in the field of medicine; product research for others in the field of food products; research for developing new products; industrial analysis and research services in the field of chemistry; assessment of the effectiveness of industrial chemical products; consultant services in the field of scientific research; providing advisory information services in the field of scientific instruments; advice relating to scientific research; providing advice in connection with medical science; professional advice relating to food technology; technical consultancy with respect to product development; development of medicines; development and testing of chemical production methods; scientific laboratory services
Case File Event Statements
  • 9/25/2023 - a year ago
    26 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 9/25/2023 - a year ago
    25 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/20/2023 - a year ago
    24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/20/2023 - a year ago
    23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 6/20/2023 - a year ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/4/2023 - a year ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/4/2023 - a year ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/15/2023 - a year ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/27/2023 - a year ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/27/2023 - a year ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/27/2023 - a year ago
    16 - ASSIGNED TO LIE Type: ALIE
  • 2/27/2023 - a year ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/27/2023 - a year ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/27/2023 - a year ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/17/2023 - a year ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/16/2023 - a year ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/16/2023 - a year ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/12/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 8/22/2022 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/22/2022 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/28/2022 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/27/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/25/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/3/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 4/29/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/28/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR